Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Moderate physical activity for pregnant women at social risk

Official title: Physical Activity and Pregnant Women at Increased Social Risk: a Feasibility Study

Run by Hospital Universitari Vall d'Hebron Research Institute · NCT07394803 · Data updated 2026-11-12

This study tests whether a moderate-intensity physical activity program during pregnancy is feasible for pregnant women facing social risk.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorHospital Universitari Vall d'Hebron Research Institute
Academic / other
Locations2 sites (Barcelona and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedSeptember 30, 2026
Study endsJanuary 1, 2027
Registry record updatedMay 22, 2026
Trial IDNCT07394803 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women over 18 with antenatal care at the specified Barcelona sites and meeting local social-risk criteria.

Probably not a fit

Participants unable to engage in moderate activity due to medical contraindications or personal choice may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This non-randomized feasibility study will pilot a moderate-intensity physical activity program for pregnant women at social risk, delivered through a mix of on-site and online sessions three times weekly. Participants will complete multiple questionnaires to assess acceptability, barriers, physical activity levels, and well-being. The study also aims to understand facilitators and barriers to engagement, as well as potential effects on physical health, sleep, and quality of life. Recruitment targets women over 18 receiving antenatal care at specified Barcelona sites who meet social-risk criteria and have no contraindications to activity during pregnancy.

Why it matters

Potential benefit: If feasible, the program could provide a structured option to improve activity levels and possibly enhance well-being during pregnancy for socially vulnerable women.

How similar studies have gone: Previous studies of physical activity in pregnancy show potential benefits; feasibility of implementation in vulnerable populations is less established, making this approach exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Maternal age above 18 years old.
* Antenatal care at ASSIR Barcelona Nord (SAP Muntanya), and/or Hospital Vall d´Hebron.
* Fulfilling social risk criteria defined by the Local Protocol (13), that includes as vulnerable socioeconomical conditions: low economic income, unemployed, poor nutrition, low educational level, difficult access to perinatal healthcare and lack of social and familiar support.

Exclusion Criteria:

* Contraindications for the practice of physical activity during pregnancy according to the Spanish and/or Canadian (5,6,14)guidelines of physical activity during pregnancy (ref).
* Unable to communicate in the official language (Spanish or Catalan)
* Aiming to give birth in a different setting of the study setting.

Where it's running

  • Centros de Atenció a la salut sexual i reproductiva (ASSIR) in Barcelona Nord
    Barcelona, Spain
    Recruiting
  • Hospital Vall d´Hebron, Barcelona
    Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.